Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and Vaccines
March 12, 2024 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, March 12, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that the United States Patent and Trademark Office...
Pediatric Clinical Trials Market Poised for Growth Amid Innovative Treatments and Advanced Research Technologies
March 08, 2024 09:26 ET
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Pediatric Clinical Trials Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global pediatric clinical...
Damon Runyon launches new pediatric cancer fellowship in partnership with St. Jude Children’s Research Hospital
June 08, 2023 08:00 ET
|
St. Jude Children's Research Hospital
NEW YORK, N.Y. and MEMPHIS, Tenn., June 08, 2023 (GLOBE NEWSWIRE) -- The Damon Runyon Cancer Research Foundation and St. Jude Children’s Research Hospital announced a new pediatric-focused...
Physicians’ Education Resource® supports Make-A-Wish Foundation by donating for each attendee at annual oncology meeting symposia in Chicago, Illinois
June 01, 2023 12:40 ET
|
Physicians' Education Resource®
CRANBURY, N.J., June 01, 2023 (GLOBE NEWSWIRE) -- Physicians’ Education Resource, LLC (PER®), a top educational resource for health care professionals across all specialties to advance patient care,...
Physicians' Education Resource Announces Inaugural International Congress on Pediatric Oncology Scheduled for Dec. 16
November 08, 2022 14:16 ET
|
Physicians' Education Resource®
CRANBURY, N.J., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Physicians' Education Resource®, LLC (PER®), a top educational resource for health care professionals across all specialties to advance patient...
AI Therapeutics Announces the Acquisition of Novel Cancer Drug Candidate EC-8042 (AIT-102)
April 25, 2022 10:30 ET
|
AI Therapeutics, Inc.
GUILFORD, Conn., April 25, 2022 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., an AI driven clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, today announced the...
Provectus Biopharmaceuticals Names Aru Narendran, MD, PhD to Scientific Advisory Board
April 14, 2022 07:30 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, April 14, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced the addition of Aru Narendran, MD, PhD to the Company’s Scientific Advisory Board. Dr. Narendran is a...
2021 Outlook on Pediatrics Partnering Deals - In-depth Review of Deals Entered into by the Top 25 Most Active Dealmakers
January 04, 2022 05:23 ET
|
Research and Markets
Dublin, Jan. 04, 2022 (GLOBE NEWSWIRE) -- The "Global Pediatrics Partnering 2010-2021: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering. Global...
Global Pediatrics Partnering Directory 2010-2021: Comprehensive Access to 500+ Pediatrics Deal Records
March 12, 2021 07:08 ET
|
Research and Markets
Dublin, March 12, 2021 (GLOBE NEWSWIRE) -- The "Global Pediatrics Partnering 2010-2021: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. Global...
THE ACCESS TO CHILDHOOD CANCER ESSENTIALS (ACCESS) INITIATIVE ANNOUNCES TRANSFORMATIVE PROGRAMS TO INCREASE ACCESS TO CRITICAL MEDICINES
January 14, 2019 09:00 ET
|
The American Childhood Cancer Organization
Washington D.C., Jan. 14, 2019 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE – January 13, 2019 – Washington, D.C. Access to Childhood Cancer Essentials (ACCESS) today announced two initiatives with...